Conference Call with Jupiter Life Line Hospitals Management and Analysts on Q1FY26 Performance and Outlook. Listen to the full earnings transcript.
Healthcare Facilities company Jupiter Life Line Hospitals announced H1FY25 results Total Income Rs 612.8 crore with growth 20.5 % YoY. EBITDA Rs 141.9 crore with growth 22.3 % YoY. PAT Rs 96.1 crore with growth 9.6 % YoY. Ankit Thakker ED & CEO, Jupiter Life Line Hospitals, said: “We are pleased to report a 20.5% increase in total income, reaching Rs 612.8 crore in H1FY25, up from Rs 508.4 crore in H1FY24. EBITDA rose by 22.3% to Rs 141.9 crore, compared to Rs 116.1 crore in H1FY24, while PAT grew by 9.6% to Rs 96.1 crore in H1FY25, up from Rs 87.7 crore in H1FY24. This growth has been driven by strong operational performance across all three hospitals, reflected in higher occupancy rates and increased ARPOB. In Q2FY25, we added 22 beds at our Pune hospital and are in the process of adding 75 new beds at our Indore hospital, which is expected to be operational by Q4FY25. We are focused on expanding the Jupiter brand, enhancing management professionalism, and increasing our footprint. With this regards, the construction of our Dombivli hospital is progressing on schedule. For our Pune hospitals, we are in the advanced stages of obtaining the necessary regulatory approvals. With the addition of these two new facilities, our total bed capacity will increase to ~2,200 beds, and we are currently identifying another location to raise our total capacity to ~2,500 beds. We have effectively leveraged our core strengths to drive growth, solidifying our position as a leading healthcare provider in Western India. By aligning these initiatives with our long-term growth vision, we have established a strong foundation for sustainable expansion and improved patient care.” Result PDF